231 related articles for article (PubMed ID: 15221469)
1. A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
Fu X; Tan L; Liu S; Li H; Chen L; Qin J; Wu M; Wang H
J Cancer Res Clin Oncol; 2004 Sep; 130(9):514-20. PubMed ID: 15221469
[TBL] [Abstract][Full Text] [Related]
2. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
[TBL] [Abstract][Full Text] [Related]
3. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways.
Fu J; Chen Y; Cao J; Luo T; Qian YW; Yang W; Ren YB; Su B; Cao GW; Yang Y; Yan YQ; Shen F; Wu MC; Feng GS; Wang HY
Hepatology; 2011 Jan; 53(1):181-92. PubMed ID: 21254169
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
Radwan NA; Ahmed NS
Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples.
Siddiqui MT; Saboorian MH; Gokaslan ST; Ashfaq R
Cancer; 2002 Feb; 96(1):49-52. PubMed ID: 11836703
[TBL] [Abstract][Full Text] [Related]
6. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
Röcken C; Licht J; Roessner A; Carl-McGrath S
J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
Lau SK; Prakash S; Geller SA; Alsabeh R
Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
Tsuji M; Kashihara T; Terada N; Mori H
Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
[TBL] [Abstract][Full Text] [Related]
9. p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis.
Qian YW; Chen Y; Yang W; Fu J; Cao J; Ren YB; Zhu JJ; Su B; Luo T; Zhao XF; Dai RY; Li JJ; Sun W; Wu MC; Feng GS; Wang HY
Gastroenterology; 2012 Jun; 142(7):1547-58.e14. PubMed ID: 22387393
[TBL] [Abstract][Full Text] [Related]
10. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.
Fujikura K; Yamasaki T; Otani K; Kanzawa M; Fukumoto T; Ku Y; Hirose T; Itoh T; Zen Y
Am J Surg Pathol; 2016 May; 40(5):689-96. PubMed ID: 26735860
[TBL] [Abstract][Full Text] [Related]
11. [The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].
Pozharisskiĭ KM; Granov DA; Ten VP; Kubaĭbergenova AG; Leenman EE; Rasskazov AI
Vopr Onkol; 2008; 54(4):417-33. PubMed ID: 18942395
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
Lei JY; Bourne PA; diSant'Agnese PA; Huang J
Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
[TBL] [Abstract][Full Text] [Related]
13. The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signaling.
Dong LW; Yang GZ; Pan YF; Chen Y; Tan YX; Dai RY; Ren YB; Fu J; Wang HY
Cell Res; 2011 Aug; 21(8):1248-61. PubMed ID: 21691299
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Chu PG; Ishizawa S; Wu E; Weiss LM
Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material.
Al-Muhannadi N; Ansari N; Brahmi U; Satir AA
Ann Hepatol; 2011; 10(4):508-15. PubMed ID: 21911893
[TBL] [Abstract][Full Text] [Related]
16. p28GANK inhibits endoplasmic reticulum stress-induced cell death via enhancement of the endoplasmic reticulum adaptive capacity.
Dai RY; Chen Y; Fu J; Dong LW; Ren YB; Yang GZ; Qian YW; Cao J; Tang SH; Yang SL; Wang HY
Cell Res; 2009 Nov; 19(11):1243-57. PubMed ID: 19736567
[TBL] [Abstract][Full Text] [Related]
17. Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma.
Tan L; Fu XY; Liu SQ; Li HH; Hong Y; Wu MC; Wang HY
Liver Int; 2005 Jun; 25(3):667-76. PubMed ID: 15910504
[TBL] [Abstract][Full Text] [Related]
18. p28(GANK) associates with p300 to attenuate the acetylation of RelA.
Ren YB; Luo T; Li J; Fu J; Wang Q; Cao GW; Chen Y; Wang HY
Mol Carcinog; 2015 Dec; 54(12):1626-35. PubMed ID: 25400040
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance.
Fu XY; Wang HY; Tan L; Liu SQ; Cao HF; Wu MC
World J Gastroenterol; 2002 Aug; 8(4):638-43. PubMed ID: 12174370
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics.
Wee A
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):266-72. PubMed ID: 16932016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]